辅助受孕女性胚胎移植优化干预:一项全面系统综述与荟萃分析
该研究系统检索至2021年3月的随机对照试验,纳入188项RCT(38种干预,59530名参与者),评估胚胎移植前后24小时内的干预措施。超声引导、软导管、透明质酸可提高临床妊娠率;G-CSF、阿托西班、hCG显示获益趋势但需更大试验;移植后卧床休息与临床妊娠率降低相关,不应推荐。
要点
- 超声引导移植、软导管和透明质酸可提高临床妊娠率。
- G-CSF、阿托西班和hCG显示临床妊娠率获益趋势,但需更大试验验证。
- 移植后卧床休息与临床妊娠率降低相关,不应推荐。
核心结论
- 超声引导、软导管和透明质酸在胚胎移植时似乎可提高临床妊娠率。
- 阿托西班、G-CSF和hCG显示临床妊娠率增加趋势,但需更大试验才能在临床实践中采用。
- 移植后卧床休息与临床妊娠率降低相关,不应推荐。
研究设计与样本
- 全面系统综述与荟萃分析,检索MEDLINE、EMBASE和Cochrane CENTRAL自建库至2021年3月。
- 纳入所有在胚胎移植前/后24小时内评估干预措施的随机对照试验,对象为接受IVF/ICSI的女性。
- 共纳入188项RCT(38种干预,59530名参与者),中位样本量200(范围26-1761)。
主要发现
- 超声引导 vs 临床触觉引导移植(n=24,RR 1.265,95% CI 1.151-1.391,I²=38.53%)。
- 透明质酸 vs 常规护理(n=9,RR 1.457,95% CI 1.197-1.261,I²=46.48%)。
- 软导管 vs 硬导管(n=27,RR 1.122,95% CI 1.028-1.224,I²=57.66%)。
- G-CSF(n=4,RR 1.774,95% CI 1.252-2.512,I²=0)、阿托西班(n=7,RR 1.493,95% CI 1.184-1.882,I²=68.27%)和hCG(n=17,RR 1.232,95% CI 1.099-1.382,I²=57.76%)也显示获益。
- 移植后卧床休息与临床妊娠率降低相关(n=6,RR 0.857,95% CI 0.741-0.991,I²=0.01%)。
关键数值与推荐
- 主要结局为胚胎移植后经超声确认的临床妊娠率。
- 纳入RCT的随机化低偏倚风险为118/188(62.8%),失访低偏倚风险为105/188(55.8%),但存在显著发表偏倚(Egger检验P=0.001)。
临床怎么用
- 胚胎移植时使用超声引导、软导管和透明质酸似乎可提高临床妊娠率。
- 阿托西班、G-CSF和hCG在临床实践中采用前需更大试验验证。
- 移植后卧床休息不应推荐。
局限性
- 存在显著发表偏倚(Egger检验P=0.001)。
- 其他重要结局(包括流产和活产)的效应估计受纳入RCT报告差异的限制。
- 阿托西班(I²=68.27%)、hCG(I²=57.76%)和软导管(I²=57.66%)等分析存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several interventions and techniques are suggested to improve the outcome of embryo transfer (ET) in assisted conception. However, there remains no consensus on the optimal practice, with high variations among fertility specialists. OBJECTIVE AND RATIONALE: We conducted a comprehensive systematic review and meta-analyses of randomized controlled trials (RCTs) aiming to identify effective interventions that could be introduced around the time of ET to improve reproductive outcomes. SEARCH METHODS: We searched the electronic databases (MEDLINE, EMBASE and Cochrane CENTRAL) from inception until March 2021 using a multi-stage search strategy of MeSH terms and keywords, and included all RCTs that evaluated an intervention in the 24-h period before/after ET in women undergoing IVF/ICSI. Our primary outcome was clinical pregnancy rate post-ET confirmed as viable pregnancy on ultrasound scan. We assessed the risk of bias in included trials and extracted data in duplicate. We pooled data using a random-effect meta-analysis and reported using risk ratio (RR) with 95% CI. We explored publication bias and effect modifiers using subgroup analyses. OUTCOMES: Our search yielded 3685 citations of which we included 188 RCTs (38 interventions, 59 530 participants) with a median sample size of 200 (range 26-1761). The quality of included RCTs was moderate with most showing a low risk of bias for randomization (118/188, 62.8%) and attrition (105/188, 55.8%) but there was a significant risk of publication bias (Egger's test P = 0.001). Performing ET with ultrasound guidance versus clinical touch (n = 24, RR 1.265, 95% CI 1.151-1.391, I2 = 38.53%), hyaluronic acid versus routine care (n = 9, RR 1.457, 95% CI 1.197-1.261, I2 = 46.48%) and the use of a soft versus hard catheter (n = 27, RR 1.122, 95% CI 1.028-1.224, I2 = 57.66%) led to higher clinical pregnancy rates. Other pharmacological add-ons also showed a beneficial effect including granulocyte colony-stimulating factor (G-CSF: n = 4, RR 1.774, 95% CI 1.252-2.512, I2 = 0), Atosiban (n = 7, RR 1.493, 95% CI 1.184-1.882, I2 = 68.27%) and hCG (n = 17, RR 1.232, 95% CI 1.099-1.382, I2 = 57.76%). Bed rest following ET was associated with a reduction in clinical pregnancy (n = 6, RR 0.857, 95% CI 0.741-0.991, I2 = 0.01%). Other commonly used interventions, such as non-steroidal anti-inflammatory drugs, prophylactic antibiotics, acupuncture and cervical mucus removal, did not show a significant benefit on reproductive outcomes. Our effect estimates for other important outcomes, including miscarriage and live birth, were limited by the varied reporting across included RCTs. WIDER IMPLICATIONS: Using ultrasound guidance, soft catheters and hyaluronic acid at the time of ET appears to increase clinical pregnancy rates. The use of Atosiban, G-CSF and hCG showed a trend towards increased clinical pregnancy rate, but larger trials are required before adopting these interventions in clinical practice. Bed rest post-ET was associated with a reduction in clinical pregnancy and should not be recommended.
引用
- Tyler B, Walford H, Tamblyn J, et al. Interventions to optimize embryo transfer in women undergoing assisted conception: a comprehensive systematic review and meta-analyses. Hum Reprod Update. 2022. PMID: 35325124. doi:10.1093/humupd/dmac009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。